Shawnte Mitchell's most recent trade in Olema Pharmaceuticals Inc was a trade of 25,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Olema Pharma Inc | Shawnte M. Mitchell | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 25,000 | 410,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Shawnte M. Mitchell | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.37 per share. | 03 Mar 2026 | 25,000 | 25,000 | - | 4.4 | 109,250 | Common Stock |
| Olema Pharma Inc | Shawnte M. Mitchell | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.25 per share. | 03 Mar 2026 | 24,767 | 233 | - | 24.3 | 600,600 | Common Stock |
| Olema Pharma Inc | Shawnte M. Mitchell | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.37 per share. | 03 Mar 2026 | 15,000 | 15,000 | - | 4.4 | 65,550 | Common Stock |
| Olema Pharma Inc | Shawnte M. Mitchell | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 15,000 | 435,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Shawnte M. Mitchell | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 23.01 per share. | 03 Mar 2026 | 15,000 | 0 | - | 23.0 | 345,150 | Common Stock |
| Olema Pharma Inc | Shawnte M. Mitchell | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.69 per share. | 03 Mar 2026 | 233 | 0 | - | 24.7 | 5,753 | Comon Stock |
| Olema Pharma Inc | Shawnte M. Mitchell | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 220,000 | 220,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Shawnte M. Mitchell | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 56,250 | 56,250 | - | - | Performance Stock Options (Right to Buy) | |
| Olema Pharma Inc | Shawnte M. Mitchell | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 450,000 | 450,000 | - | - | Stock Option (Right to Buy) |